| 000 | 01556 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512153304.0 | ||
| 264 | 0 | _c19720202 | |
| 008 | 197202s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.1971.tb30762.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFlacke, W E | |
| 245 | 0 | 0 |
_aGermine mono- and diacetate in myasthenia gravis. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _cSep 1971 |
||
| 300 |
_a316-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetates _xadministration & dosage |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscles _xdrug effects |
| 650 | 0 | 4 |
_aMyasthenia Gravis _xdrug therapy |
| 650 | 0 | 4 | _aPhytotherapy |
| 650 | 0 | 4 | _aPlants, Medicinal |
| 650 | 0 | 4 | _aPlants, Toxic |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUlnar Nerve _xdrug effects |
| 650 | 0 | 4 |
_aVeratrum _xadministration & dosage |
| 650 | 0 | 4 |
_aVital Capacity _xdrug effects |
| 700 | 1 | _aBlume, R P | |
| 700 | 1 | _aScott, W R | |
| 700 | 1 | _aFoldes, F F | |
| 700 | 1 | _aOsserman, K E | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 183 _gp. 316-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1971.tb30762.x _zAvailable from publisher's website |
| 999 |
_c5289516 _d5289516 |
||